Lv, F., Si, W., Xu, X., He, X., Wang, Y., Li, Y., & Li, F. (2024). RUNX2 prompts triple negative breast cancer drug resistance through TGF-β pathway regulating breast cancer stem cells. Elsevier.
Chicago-viite (17. p.)Lv, Fengxu, Wentao Si, Xiaodan Xu, Xiaogang He, Ying Wang, Yetian Li, ja Feifei Li. RUNX2 Prompts Triple Negative Breast Cancer Drug Resistance Through TGF-β Pathway Regulating Breast Cancer Stem Cells. Elsevier, 2024.
MLA-viite (9. p.)Lv, Fengxu, et al. RUNX2 Prompts Triple Negative Breast Cancer Drug Resistance Through TGF-β Pathway Regulating Breast Cancer Stem Cells. Elsevier, 2024.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.